C

Cocrystal Pharma
D

COCP

1.74000
USD
0.02
(1.16%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
-1
Market Cap
17,702,395
OverviewSignalsIdeasNews
Related Instruments
    A
    AYTU
    -0.05000
    (-1.89%)
    2.60000 USD
    C
    CRT
    -0.180
    (-1.74%)
    10.160 USD
    D
    DFFN
    0
    (0%)
    0.000000 USD
    E
    ENZ
    0.00000
    (0.00%)
    1.14000 USD
    G
    GLMD
    -0.00350
    (-1.12%)
    0.31000 USD
    T
    TRIB
    -0.18000
    (-6.04%)
    2.80000 USD
    More
News

Title: Cocrystal Pharma

Sector: Healthcare
Industry: Biotechnology
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).